These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10668412)

  • 41. "Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group.
    Gaab MR; Trost HA; Alcantara A; Karimi-Nejad A; Moskopp D; Schultheiss R; Bock WJ; Piek J; Klinge H; Scheil F
    Zentralbl Neurochir; 1994; 55(3):135-43. PubMed ID: 7810251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
    Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
    Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study.
    Walters MR; Kaste M; Lees KR; Diener HC; Hommel M; De Keyser J; Steiner H; Versavel M
    Cerebrovasc Dis; 2005; 20(5):304-9. PubMed ID: 16131799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
    Theadom A; Mahon S; Barker-Collo S; McPherson K; Rush E; Vandal AC; Feigin VL
    Eur J Neurol; 2013 Aug; 20(8):1135-44. PubMed ID: 23384428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.
    Dempsey RJ; Başkaya MK; Doğan A
    Neurosurgery; 2000 Aug; 47(2):399-404; discussion 404-6. PubMed ID: 10942013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.
    Lees KR; Lavelle JF; Cunha L; Diener HC; Sanders EA; Tack P; Wester P;
    Cerebrovasc Dis; 2001; 11(1):20-9. PubMed ID: 11173790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of the Glutamate NMDA Receptor Antagonist Memantine as Adjunctive Treatment in Borderline Personality Disorder: An Exploratory, Randomised, Double-Blind, Placebo-Controlled Trial.
    Kulkarni J; Thomas N; Hudaib AR; Gavrilidis E; Grigg J; Tan R; Cheng J; Arnold A; Gurvich C
    CNS Drugs; 2018 Feb; 32(2):179-187. PubMed ID: 29549516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).
    Teal P; Davis S; Hacke W; Kaste M; Lyden PD; ; Fierus M;
    Stroke; 2009 Nov; 40(11):3518-25. PubMed ID: 19745176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers.
    Muir KW; Grosset DG; Lees KR
    Clin Neuropharmacol; 1997 Aug; 20(4):311-21. PubMed ID: 9260729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study.
    Schneider WN; Drew-Cates J; Wong TM; Dombovy ML
    Brain Inj; 1999 Nov; 13(11):863-72. PubMed ID: 10579658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).
    Lemming D; Sörensen J; Graven-Nielsen T; Lauber R; Arendt-Nielsen L; Gerdle B
    Eur J Pain; 2007 Oct; 11(7):719-32. PubMed ID: 17197214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
    Muir KW
    Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CP-101606 Pfizer Inc.
    Chazot PL
    Curr Opin Investig Drugs; 2000 Nov; 1(3):370-4. PubMed ID: 11249721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
    Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
    Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.